Evidence map›Paper›PMID 35070520›Full record

ArticleACS sustainable chemistry & engineering2021

Enzyme Storage and Recycling: Nanoassemblies of α-Amylase and Xylanase Immobilized on Biomimetic Magnetic Nanoparticles.

Karima Salem, Ylenia Jabalera, Jose David Puentes-Pardo, Jesus Vilchez-Garcia, Adel Sayari, Aïda Hmida-Sayari, Concepcion Jimenez-Lopez, Massimiliano Perduca

Open access · hybridAbstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Facile Cellulase Immobilisation on Bioinspired Silica.Nanomaterials (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Karima SalemCentre de Biotechnologie de Sfax (CBS), Université de Sfax, Route de Sidi Mansour Km 6, BP "1177", 3018 Sfax, Tunisie.
Ylenia JabaleraDepartamento de Microbiologia, Universidad de Granada, Campus de Fuentenueva s/n, 18071 Granada, Spain.
Jose David Puentes-PardoDepartamento de Microbiologia, Universidad de Granada, Campus de Fuentenueva s/n, 18071 Granada, Spain.
Jesus Vilchez-GarciaDepartamento de Microbiologia, Universidad de Granada, Campus de Fuentenueva s/n, 18071 Granada, Spain.
Adel SayariENIS, Université de Sfax, BP "1173", 3038 Sfax, Tunisie.
Aïda Hmida-SayariCentre de Biotechnologie de Sfax (CBS), Université de Sfax, Route de Sidi Mansour Km 6, BP "1177", 3018 Sfax, Tunisie.
Concepcion Jimenez-LopezDepartamento de Microbiologia, Universidad de Granada, Campus de Fuentenueva s/n, 18071 Granada, Spain.ORCID 0000-0002-5645-2079
Massimiliano PerducaDepartment of Biotechnology, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy.ORCID 0000-0001-8291-0523
Universidad de Granada · ESUniversity of Sfax · TNUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immobilization of enzymes has been extensively required in a wide variety of industrial applications as a way to ensure functionality and the potential of enzyme recycling after use. In particular, enzyme immobilization on magnetic nanoparticles (MNPs) could offer reusability by means of magnetic recovery and concentration, along with increased stability and robust activity of the enzyme under different physicochemical conditions. In the present work, microbial α-amylase (AmyKS) and xylanase (XAn11) were both immobilized on different types of MNPs [MamC-mediated biomimetic MNPs (BMNPs) and inorganic MNPs] by using two different strategies (electrostatic interaction and covalent bond). AmyKS immobilization was successful using electrostatic interaction with BMNPs. Instead, the best strategy to immobilize XAn11 was using MNPs through the hetero-crosslinker 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and

Identifiers

PMID35070520
PMCPMC8765010
OpenAlexW3133588212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.